Low cytotoxic tissue adhesive based on oxidized dextran and epsilon-poly- l -lysine

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 8, 2014, Pages 2511-2520

  Hyon, Suong Hyu ^a   Nakajima, Naoki ^b   Sugai, Hajime ^b   Matsumura, Kazuaki ^c  

^a KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^b BMG Incorporated Kyoto   (Japan)

^c JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

adhesive; cytotoxicity; dextran; epsilon poly(l lysine); periodate

Indexed keywords

ADHESIVES; ALDEHYDES; AMINO ACIDS; CYTOTOXICITY; GELATION; HYDROGELS; MEDICAL APPLICATIONS; OXIDATION;

BIOMEDICAL APPLICATIONS; EPSILON-POLY(L -LYSINE); LOW CYTOTOXICITIES; OXIDIZED DEXTRANS; PERIODATE; PERIODATE OXIDATION; PRIMARY AMINO GROUPS; SHEAR ADHESION STRENGTHS;

DEXTRAN;

ACID ANHYDRIDE; ALBUMIN; ALDEHYDE; DEXTRAN; EPSILON POLY LEVO LYSINE; FIBRIN GLUE; GELATIN; GLUTARALDEHYDE; PERIODATE; POLY(ALLYL AMINE); POLYLYSINE; POLYMER; SUCCINIC ANHYDRIDE; UNCLASSIFIED DRUG; PERIODIC ACID; SOLUTION AND SOLUBILITY; TISSUE ADHESIVE;

ACYLATION; ADHESION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GELATION; HYDROGEL; MOUSE; NONHUMAN; OXIDATION; TENSILE STRENGTH; ANIMAL; CELL DEATH; CELL LINE; CHEMISTRY; DRUG EFFECTS; OXIDATION REDUCTION REACTION; PROTON NUCLEAR MAGNETIC RESONANCE; SHEAR STRENGTH; SOLUTION AND SOLUBILITY; TIME; TOXICITY;

ACYLATION; ALDEHYDES; ANHYDRIDES; ANIMALS; CELL DEATH; CELL LINE; DEXTRANS; MICE; OXIDATION-REDUCTION; PERIODIC ACID; POLYLYSINE; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SHEAR STRENGTH; SOLUTIONS; TIME FACTORS; TISSUE ADHESIVES;

EID: 84903310665     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34923     Document Type: Article

References (50)

1. Ryou M, Thompson CC,. Tissue adhesives: A Review. Tech Gastrointest Endosc 2006; 8: 33-37.
2. Doraiswamy NV, Baig H, Hammett S, Hutton M,. Which tissue adhesive for wounds? Injury Int J Care Injur 2003; 34: 564-567.
3. Ramond MJ, Valla D, Gotlib JP, Rueff B, Benha-Moou JP,. Endoscopic obturation of esophagogastric varices with bucrylate. I Clinical study of 49 patients. Gastroenterol Clin Biol 1986; 10: 575-579.
4. Bhasin DK, Sharma BC, Prasad H, Singh K,. Endoscopic removal of sclerotherapy needle from gastric varix after n-butyl-2-cyanoacrylate injection. Gastrointest Endosc 2000; 51: 497-498.
5. Bhatia SK, Arthur SD, Chenault HK, Kodokian GK,. Interactions of polysaccharide-based tissue adhesives with clinically relevant fibroblast and macrophage cell lines. Biotechnol Lett 2007; 29: 1645-1649.
6. Torchiana DF,. Polyethylene glycol based synthetic sealants: Potential uses in cardiac surgery. J Card Surg 2003; 18: 504-506.
7. Spotnitz WD, Prabbu R,. Fibrin sealant tissue adhesive: Review and update. J Long Term Eff Med Implants 2005; 15: 245-270.
8. Sequin JR, Pricard E, Fapier JM, Chaptal PA,. Aortic value repair with fibrin glue for type A acute aortic dissection. Ann Throac Surg 1994; 58: 304-307.
9. Rutgeerts P, Rauws E, Wara P, Swain P, Hoos A, Solleder E, Halttunen J, Dobrilla G, Richter G, Prassler R,. Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer. Lancet 1997; 350: 692-696.
10. Hwang TL, Chen MF,. Randomized trial of fibrin tissue glue for low output enterocutaneous fistula. Br J Surg 1996; 83: 112.
11. Fernandez FF, Richter A, Freudenberg S, Wendl K, Manegold BC,. Treatment of endoscopic esophageal perforation. Surg Endsc 1999; 13: 962-966.
12. Ortel TL, Charles LA, Keller FG, Marcom PK, Oldham Jr HN, Kane WH, Macik BG,. Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis. Am J Hematol 1994; 45: 128-135.
13. MacGillivray TE,. Fibrin sealants and glues. J Card Surg 2003; 18: 480-485.
14. Feito BA, Rath AM, Longchamptc E, Azorin J,. Experimental study on the in vivo behaviour of a new collagen gluein lung surgery. Eur J Cardio-Thorac Surg 2000; 17: 8-13.
15. Bak JB, Singth A, Shekarriz B,. Use of gelatin matrix thrombin tissue sealant as an effective hemostatic agent during laparoscopic partial nephrectomy. J Urol 2004; 171: 780-782.
16. Canonico S,. The use of human fibrin glue in the surgical operations. Acta Biomed 2003; 74: 21-25.
17. Siedentop KH, Park JJ, Shah AN, Bhattacharyya TK, O'Grady KM,. Safety and efficacy of currently available fibrin tissue adhesives. Am J Otolaryngol 2001; 22: 230-235.
18. Silver FH, Wang MC, Pins GD,. Preparation and use of fibrin glue in surgery. Biomaterials 1995; 16: 891-903.
19. Richer F, Schnorr D, Deger S, Turk I, Rogias J, Wille A, Loening SA,. Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thronbin tisuue sealant (Floseal). Urology 2003; 61: 73-77.
20. Friedman M, Schalch P,. Middle turbinate medialization with bovine serum alubumin tisuue adhesive (Bioglue). Oper Tech Otol 2007; 18: 307-309.
21. Hidas G, Kastin A, Mullerad M, Shental J, Moskovitz B, Nativ O,. Suturless nephron-sparing suegery: Use of albumin glutaraldehyde tissue adhesive (BioGlue). Urology 2006; 67: 697-700.
22. Lustgarten L, Abadi JR, Sancevic R, Sancevic R, Meneses P, Morrel AP, Lugo J,. Use of a protein-based tissue adhesive as an aid for the surgical reconstruction of advanced and recurrent skin cancer tumors to the head and neck region: A technical report. Surg Neurol 2007; 68: 53-59.
23. LeMaire SA, Schmittling ZC, Coselli JS, Ündar A, Deady BA, Clubb FJ Jr, Fraser CD,. BioGlue surgical adhesive impairs aortic growth and causes anastomotic strictures. Ann Thorac Surg 2002; 73: 1500-1505.
24. Erasmi AW, Sievers HH, Wohlschläger C,. Inflammatory response after BioGlue application. Ann Thorac Surg 2002; 73: 1025-1026.
25. Furst W, Banerjee A,. Release of glutaraldehyde from an albumin-glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity. Ann Thorac Surg 2005; 79: 1522-1529.
26. Reece TB, Maxey TS, Kron IL,. A prospectus on tissue adhesives. Am J Surg 2001; 182: 40-44.
27. Nakajima N, Sugai H, Tsutsumi S, Hyon SH,. Self-degradable bioadhesive. Key Eng Mater 2007; 342-343: 713-716.
28. Yamanaka K, Maruyama C, Takagi H, Hamano Y,. Epsilon-poly-L-lysine dispersity is controlled by a highly unusual nonribosomal peptide synthetase. Nat Chem Biol 2008; 4: 766-772.
29. Saimura M, Takehara M, Mizukami S, Kataoka K, Hirohara H,. Biosynthesis of nearly monodispersed poly(epsilon-L-lysine) in Streptomyces species. Biotechnol Lett 2008; 30: 377-385.
30. Zhou C, Li P, Qi X, Sharif ARM, Poon YF, Cao Y, Chen MW, Leong SSJ, Chan-Park MB,. A photopolymerized antimicrobial hydrogel coating derived from epsilon-poly-L-lysine. Biomaterials 2011; 32: 2704-2712.
31. Mehvar R,. Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J Control led Release 2000; 69: 1-25.
32. Ferreira L, Rafael A, Lamghari M, Barbosa MA, Gil MH, Cabrita AMS, Dordick JS,. Biocompatibility of chemoenzymatically derived dextran-acrylate hydrogels. J Biomed Mater Res 2004; 68(A): 584-596.
33. Mo X, Iwata H, Matsuda S, Ikada Y., Soft tissue adhesive composed of modified gelatin. J Biomater Sci Polym Edn 2000; 11: 345-351.
34. McGrath R,. Proten measurement by ninhydrine determination of amino acids released by alkaline hydrolysis. Anal Biochem 1972; 49: 95-102.
35. Shazly TM, Artzi N, Boehning F, Edelman ER., Viscoelastic adhesive mechanics of aldehyde-mediated soft tissue sealants. Biomaterials 2008; 29: 4584-4591.
36. Kakinoki S, Taguchi T, Saito H, Tanaka J, Tateishi T,. Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: Characterization and in vitro evaluation. Eur J Pharm Biopharm 2007; 66: 383-390.
37. Mark DC, Belov L, Davay MW, Davey RA, Kidman AD,. The MTT cell vaiability assay for cytotoxicity testing in multidrug-resistant human leukemic cells. Leukemia Res 1992; 16: 1165-1173.
38. Habeeb AFSA,. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 1966; 14: 328-336.
39. Zeiger E, Gollapudi B, Spencer P,. Genetic toxicity and carcinogenicity studies of glutaraldehyde-A review. Mutat Res 2005; 589: 136-151.
40. Zissu D, Gagnaire F, Bonnet P,. Nasal and pulmonary toxicity of glutaraldehyde in mice. Toxicol Lett 1994; 71: 53-62.
41. Nishi C, Nakajima N, Ikada Y,. In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification. J Biomed Mater Res 1995; 29: 829-834.
42. Strehin J, Nahas Z, Arora K, Nguyen T, Elisseeff J,. A versatile pH sensitive chondroitin sulfate-PEG tissue adhesive and hydrogel. Biomaterials 2010; 31: 2788-2797.
43. Ito T, Yeo Y, Highly CB, Bellas E, Kohane DS,. Dextran-based in situ cross-linked injectable hydrogels to prevent peritoneal adhesions. Biomaterials 2007; 28: 3418-3426.
44. Maia J, Ferreira L, Carvalho R,. Synthesis and characterization of new injectable and degradable dextran-based hydrogels. Polymer 2005; 46: 9604-9614.
45. Sloan JW, Alexander BH, Lohmar RL, Wolff IA, Rist CE,. Determination of dextran structure by periodate oxidation techniques. J Am Chem Soc 1954; 76: 4429-4434.
46. Drobchenko SN, Isaeva-Ivanova LS, Kleiner AR, Eneyskaya EV,. Aldo-enol transition in periodate-oxidized dextrans. Carbohyde Res 1996; 280: 171-176.
47. Yamagata M, Kawano T, Shiba K, Mori T, Katayama Y, Niidome T,. Structural advantage of dendritic poly(L-lysine) for gene delivery into cells. Bioorg Med Chem 2007; 15: 526-532.
48. Dai J, Zou S, Pei Y, Cheng D, Ai H, Shuai X,. Polyethylenimine-grafted copolymer of poly(L-lysine) and poly(ethylene glycol) for gene delivery. Biomaterials 2011; 32: 1694-1705.
49. Zhou Y, Li Y,. Studies of interaction between poly(allylamine hydrochloride) and double helix DNA by spectral methods. Biophys Chem 2004; 107: 273-281.
50. Lv H, Zhang S, Wang B, Cui S, Yan J,. Toxicity of cationic lipids and cationic polymers in gene delivery. J Controll Release 2006; 114: 100-109.